Natzold Infusion is a bisphosphonate used to treat osteoporosis and hypercalcemia in cancer patients. It slows bone breakdown by suppressing osteoclast activity, helping maintain bone density and reduce fracture risk in postmenopausal women or those on steroids. In hypercalcemia, it lowers excess calcium levels in the blood by reducing bone resorption. Regular exercise and dietary adjustments support its effectiveness
